Syncom Formulations (India) Limited (NSE:SYNCOMF)
India · Delayed Price · Currency is INR 13.94
+0.14 (1.01%)
May 18, 2026, 3:30 PM IST
NSE:SYNCOMF Market Cap
NSE:SYNCOMF has a market cap or net worth of 12.83 billion as of May 18, 2026. Its market cap has decreased by -19.89% in one year.
Market Cap
12.83B
Enterprise Value
11.39B
Revenue
5.03B
Ranking
n/a
PE Ratio
18.61
Stock Price
13.94
Market Cap Chart
Since December 31, 2001, NSE:SYNCOMF's market cap has increased from 267.05M to 12.83B, an increase of 4,704.75%. That is a compound annual growth rate of 17.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 12.83B | -4.34% |
| Dec 31, 2025 | 13.41B | -28.65% |
| Dec 31, 2024 | 18.80B | 32.98% |
| Dec 29, 2023 | 14.14B | 69.37% |
| Dec 30, 2022 | 8.35B | -23.58% |
| Dec 31, 2021 | 10.92B | 305.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 37.92B |
| Orchid Pharma | 36.14B |
| Solara Active Pharma Sciences | 27.93B |
| Indoco Remedies | 20.76B |
| Windlas Biotech | 16.45B |
| Sakar Healthcare | 15.50B |
| Jagsonpal Pharmaceuticals | 13.84B |
| Beta Drugs | 12.84B |